Answer
Revaxis is indicated from six years of age, including adolescents and adults, as a booster against diphtheria, tetanus and poliomyelitis following primary vaccination, not for primary immunisation.
Sources for this answer
- REVAXISSANOFI · emc · SmPC §4.1 Therapeutic Indications · Version 18Document updated
Sources checked